Management of Antiplatelet Therapy in CVA Patients with Acute GI Bleeding

Immediate Management Strategy

In patients with a history of cerebrovascular accident (CVA) on antiplatelet therapy who present with acute gastrointestinal bleeding, the American Heart Association recommends continuing aspirin without interruption while temporarily withholding clopidogrel (if on dual therapy), and proceeding urgently to endoscopy within 12 hours alongside hemodynamic resuscitation and intravenous proton pump inhibitors 1, 2

The American College of Gastroenterology suggests initiating hemodynamic resuscitation with intravenous fluids and transfusing packed red blood cells only if there is hemodynamic instability (persistent hypotension, tachycardia) 2
Administer high-dose intravenous proton pump inhibitors immediately upon presentation, as recommended by the American Heart Association 1, 2

For patients on aspirin monotherapy (secondary prevention post-CVA), the American Heart Association recommends continuing aspirin without interruption during the acute bleeding episode, with a mortality benefit that dramatically outweighs bleeding risk 1
The American College of Cardiology states that never discontinuing both antiplatelet agents simultaneously is crucial, as this is the most dangerous error, with a median time to coronary/cerebrovascular thrombosis as short as 7 days with both drugs withheld 1, 2

Perform endoscopy within 12 hours in all high-risk patients while continuing at least aspirin, as recommended by the American Society for Gastrointestinal Endoscopy 1, 2

Resume aspirin (if held) the same day endoscopic hemostasis is confirmed, according to the American Heart Association 2
The American College of Cardiology recommends resuming clopidogrel within 5 days after hemostasis, as platelet function returns 5-7 days after discontinuation 1

Prescribe proton pump inhibitors indefinitely to all patients continuing antiplatelet therapy after GI bleeding, as suggested by the American Gastroenterological Association 1, 4, 2

Assess the timing and type of cerebrovascular event, with recent ischemic stroke or TIA (within 6 months) being extremely high thrombotic risk, and prioritize continuing aspirin, according to the American Heart Association 7, 8
Prasugrel is contraindicated in patients with a history of stroke or TIA, as stated by the American College of Cardiology 5, 7

Holding both antiplatelet agents simultaneously creates extreme thrombotic risk, according to the American Heart Association 1, 2
Delaying endoscopy prolongs time off antiplatelet therapy and increases thrombotic risk, as stated by the American Society for Gastrointestinal Endoscopy 1, 2